SANOFI
Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new G enzyme. Its products includes prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines and other medical produc... ts. The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to 1970. In December 1999, Rhône-Poulenc and Hoechst Marion Roussel formalized their merger with the creation of the Franco-German group Aventis, one of the world’s largest pharmaceutical companies. In August 2004, Sanofi-Synthelabo acquired Aventis. The takeover was finalized on December 31 of that year, giving birth to sanofi-aventis. On May 6, 2011, sanofi-aventis simplified its name to Sanofi. Sanofi  operates in over 100 countries throughout the world.
SANOFI
Industry:
Biotechnology Health Care Life Science Manufacturing Marketing Medical Pharmaceutical Therapeutics
Founded:
1973-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.sanofi.com
Total Employee:
10001+
Status:
Active
Contact:
800-981-2491
Email Addresses:
[email protected]
Total Funding:
639.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Apache Nginx Amazon
Similar Organizations
adinotec AG
The adinotec AG with registered office in Griesheim (Germany) is active in the development, production, and marketing of innovative
Allergan France
Allergan France concentrates on manufacturing and marketing of originator pharmaceuticals.
Aseptic Technologies
Aseptic Technologies develops, manufactures and markets equipment.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
BioSystems
BioSystems researches, develops, produces and markets effective and reliable analytical systems for laboratories around the world.
CRYOFIT
CRYOFIT is involved in the research, development, and production of biological glue used during surgical intervention and medical processes.
Explera
Explera is engages in importing, manufacturing, and marketing products in the molecular biology field for research laboratories.
GABA International
GABA International is engaged in the research, development, manufacture, and marketing of oral care products.
Intana Bioscience GmbH
Lleading experts in customized assay development, screening and target/hit validation using fluorescence cross-correlation spectroscopy
JA Saúde Animal
J.A Saúde Animal specializes in research, development, manufacturing, and commercialization of products for animal health.
Jiangyuyi Chuang
Jiangyuyi Chuang engages in the research and development, manufacturing, and sales of medical testing equipment and smart wearable devices.
Kellsa Diagnostics
Kellsa Diagnostics are research, development, production and marketing of healthcare products and equipment, in particular diagnostics.
Phaseform
Phaseform develops next-generation adaptive optics systems based on innovative hardware and software
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-20 | Amunix | Amunix acquired by Sanofi | 1000 M USD |
| 2021-12-01 | Origimm | Origimm acquired by Sanofi | N/A |
| 2021-09-08 | Kadmon | Kadmon acquired by Sanofi | 1.9 B USD |
| 2021-08-03 | Translate Bio | Translate Bio acquired by Sanofi | 3.2 B USD |
| 2021-04-09 | Tidal Therapeutics | Tidal Therapeutics acquired by Sanofi | 160 M USD |
| 2021-01-11 | Kymab | Kymab acquired by Sanofi | 1.1 B USD |
| 2020-11-02 | Kiadis Pharma | Kiadis Pharma acquired by Sanofi | 308 M EUR |
| 2020-08-17 | Principia Biopharma | Principia Biopharma acquired by Sanofi | 3.68 B USD |
| 2019-12-09 | Synthorx | Synthorx acquired by Sanofi | 2.5 B USD |
| 2018-01-29 | Ablynx | Ablynx acquired by Sanofi | 3.9 B EUR |
Investors List
Blackstone Life Sciences
Blackstone Life Sciences investment in Post-IPO Equity - Sanofi
Evotec
Evotec investment in Post-IPO Equity - Sanofi
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-04 | Innovent Biologics | Sanofi investment in Post-IPO Equity - Innovent Biologics | 2.42 B HKD |
| 2022-07-12 | Areteia Therapeutics | Sanofi investment in Series A - Areteia Therapeutics | 350 M USD |
| 2022-01-10 | Exscientia | Sanofi investment in Post-IPO Equity - Exscientia | 100 M USD |
| 2021-11-18 | Owkin | Sanofi investment in Corporate Round - Owkin | 180 M USD |
| 2021-11-08 | Gyroscope Therapeutics | Sanofi investment in Corporate Round - Gyroscope Therapeutics | 60 M USD |
| 2021-02-16 | Novadiscovery | Sanofi investment in Series A - Novadiscovery | 2.5 M EUR |
| 2019-10-03 | Icosavax | Sanofi investment in Series A - Icosavax | 51 M USD |
| 2019-09-05 | Veralox Therapeutics | Sanofi investment in Seed Round - Veralox Therapeutics | 5.4 M USD |
| 2019-02-05 | Aetion | Sanofi investment in Series B - Aetion | 27 M USD |
| 2019-01-04 | BioNTech | Sanofi investment in Corporate Round - BioNTech | 80 M EUR |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.sanofi.com Semrush global rank: 242.17 K Semrush visits lastest month: 290.85 K
- Host name: ec2-52-18-193-106.eu-west-1.compute.amazonaws.com
- IP address: 52.18.193.106
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Sanofi" on Search Engine
Our Company, a global pharmaceutical company (medicines ... - Sanofi
We Are Sanofi. We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.See details»
Sanofi: global healthcare and pharmaceutical company
Mar 25, 2024 About Us. Who We Are. We are an innovative global healthcare company. Read more. Our Science. We turn the impossible into possible. Read more. Your Health. We chase the miracles of science to improve people’s lives. Read more. Our Commitment. We have reimagined a bold sustainable approach. Read more. Our Pipeline. 5.See details»
Sanofi - Wikipedia
Sanofi is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Biotechnology Industry Organization (BIO), and the Pharmaceutical Research and Manufacturers of America (PhRMA). Sanofi's vaccine subsidiary, Sanofi Pasteur, is a member of EuropaBio.See details»
Executive Committee - Sanofi
The Executive Committee of Sanofi, global healthcare and pharmaceutical company Sanofi.See details»
Governance - Sanofi
Sanofi is a publicly traded, limited liability company, incorporated under French laws, guided by a visionary Board of Directors and Executive Committee. We are incorporated under the laws of France, with securities listed on Euronext Paris, France, and the Nasdaq Global Select Market in the US.See details»
Our Strategy, transforming the practice of medicine, driving ... - Sanofi
Transforming The Practice of Medicine. Prioritization and focus are helping us unlock and maximize the potential of key medicines, vaccines, and self-care solutions for people, across our global business units: Specialty Care, Vaccines, …See details»
Where we are - Sanofi
Find out about where we are worldwide and other Sanofi companies and websites...See details»
Foundation S - Sanofi
The Sanofi Collective. We strive to create healthier futures for generations to come. We are driven by singular purpose, to improve the lives of vulnerable communities by focusing on locally led programs, supporting community-based ideas, and mobilizing collective action. Photo credit: Enda Santé. Local Action, Global Impact. Impact Report 2023.See details»
Government, Sanofi officials unveil $925M in vaccine funding in …
Mar 31, 2021 For its part, Sanofi will spend more than $455 million as well as create and maintain 1,225 highly-skilled jobs in Canada. The company will also invest at least $79 million a year to fund...See details»
Sanofi Canada is celebrating 110 years of innovative health
TORONTO, Jan. 30, 2024 /CNW/ - Sanofi, a global healthcare company, is commemorating 110 years in Canada, dedicated to the pursuit of medicines and vaccines that improve lives, and protect...See details»
Sanofi expands its social commitments, creates nonprofit unit to ...
Apr 7, 2021 SNYNF. Sanofi expands its social commitments, creates nonprofit unit to provide poorest countries with access to essential medicines. Launch of a new and more impactful global corporate social...See details»
Sanofi | LinkedIn
About us. We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the...See details»
Sanofi expands its social commitments, creates nonprofit unit to ...
PARIS, April 7, 2021 /PRNewswire/ -- In an open letter, Sanofi Chief Executive Officer Paul Hudson today outlined several key projects that the company will implement to increase the impact of...See details»
Sanofi to Launch Artificial Intelligence Centre of ... - Newswire
TORONTO, June 22, 2022 /CNW Telbec/ - Sanofi is pleased to announce the opening of an Artificial Intelligence Centre of Excellence in Toronto, joining Sanofi's global network of existing...See details»
Sanofi to open AI Centre of Excellence in Toronto
Aug 10, 2022 Sanofi’s global AI Centre of Excellence will be based in downtown Toronto and support the company’s mission to improve patients’ lives through digital innovation.See details»
Sanofi’s COVID-19 vaccine sees up to 100% efficacy in latest trial
May 17, 2021 An experimental COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in early-stage clinical trial results, enabling them to move to a late-stage study, the...See details»
Sanofi launches global health brand with non-profit treatments
LONDON, July 4 (Reuters) - French drugmaker Sanofi (SASY.PA) will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries in the first step...See details»
Press Release: Sanofi unveils new corporate brand and logo – …
Feb 3, 2022 Sanofi today unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019. Over the last 50 years, Sanofi has grown...See details»
Sanofi, GSK to seek authorization for COVID-19 vaccine
Feb 23, 2022 Drugmakers Sanofi and GlaxoSmithKline said Wednesday they will seek regulatory approval for a new COVID-19 vaccine after human trials showed it provided a high level of protection against the...See details»
Press Release: Sanofi announces changes to its Executive …
Paris, August 31st, 2023. Sanofi announces the following changes to its Executive Committee: Houman Ashrafian is appointed as Head of Research & Development, starting September 11 th, 2023....See details»